103 results
Page 5 of 6
424B5
u89cenh
24 Nov 20
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
hfvq87b
19 Nov 20
Other Events
4:58pm
8-K
EX-99.1
9719bf94g6k
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.2
s6eobozy
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
7je59l i889
20 Oct 20
Baudax Bio Provides Commercial and Corporate Update
7:30am
8-K
EX-99.1
tpfn 6q86zhv0vczotc8
22 Sep 20
Other Events
7:00am
8-K
EX-99.2
rzlg1nkplraf9wn
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.1
uf79e7reldw
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.1
fd0ca580ca47
6 Aug 20
Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from
7:15am
8-K
EX-99.1
2jma9p12
31 Jul 20
Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Meeting
8:41am
8-K
EX-99.1
gn0d3vruj w9se
20 Jul 20
Other Events
7:40am
8-K
EX-99.1
626tqt
15 Jun 20
Baudax Bio Announces Full Commercial Launch of ANJESO™ and Receipt of UniqueC-Code and Pass-Through Payment Status
8:37am
8-K
EX-99.1
147wc
8 May 20
Baudax Bio Reports First Quarter 2020 Financial Results
7:52am
DEFA14A
qrvxkah2737
1 May 20
Additional proxy soliciting materials
5:00pm
8-K
EX-99.1
qtx6z9
23 Apr 20
Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at the 45th
7:31am
424B5
qlz7oo5 seq
24 Mar 20
Prospectus supplement for primary offering
5:04pm